EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).

Supporters of EVISA includes:



Enloplatin is a platinum metallodrug developed for cancer therapy.
Chemical Synonyms   (1,1-cyclobutanedicarboxylato(2-)-O,O')(tetrahydro-4H-pyran- 4,4-dimethanamine-N,N') platinum(II)
CL 287110, CL-287110
CAS Registry No.   111523-41-2


Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )